These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36482536)

  • 1. Mass spectrometry-based identification of new serum biomarkers in patients with latent infection pulmonary tuberculosis.
    Li YX; Zheng KD; Duan Y; Liu HJ; Tang YQ; Wu J; Lin DZ; Zhang Z
    Medicine (Baltimore); 2022 Dec; 101(48):e32153. PubMed ID: 36482536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Untargeted metabolomics of pulmonary tuberculosis patient serum reveals potential prognostic markers of both latent infection and outcome.
    Wang X; Wu Z; Zeng J; Zhao Y; Zhang C; Yu M; Wang W; Chen X; Chen L; Wang J; Xu L; Zhou J; Tan Q; Wei W; Li Y
    Front Public Health; 2022; 10():962510. PubMed ID: 36457328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mass spectrometry-based identification of new serum biomarkers in patients with multidrug resistant pulmonary tuberculosis].
    Lin D; Wang W; Qiu F; Li Y; Yu X; Lin B; Chen Y; Lei C; Ma Y; Zeng J; Zhou J
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Dec; 39(12):1409-1420. PubMed ID: 31907157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Untargeted Metabolomics of Feces Reveals Diagnostic and Prognostic Biomarkers for Active Tuberculosis and Latent Tuberculosis Infection: Potential Application for Precise and Non-Invasive Identification.
    Luo D; Yang BY; Qin K; Shi CY; Wei NS; Li H; Qin YX; Liu G; Qin XL; Chen SY; Guo XJ; Gan L; Xu RL; Dong BQ; Li J
    Infect Drug Resist; 2023; 16():6121-6138. PubMed ID: 37719654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted metabolomics analysis of serum and Mycobacterium tuberculosis antigen-stimulated blood cultures of pediatric patients with active and latent tuberculosis.
    Magdalena D; Michal S; Marta S; Magdalena KP; Anna P; Magdalena G; Rafał S
    Sci Rep; 2022 Mar; 12(1):4131. PubMed ID: 35260782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between DNA Methylation Profiles and Active Tuberculosis Development from Latent Infection: a Pilot Study in Nested Case-Control Design.
    Du Y; Gao X; Yan J; Zhang H; Cao X; Feng B; He Y; He Y; Guo T; Xin H; Gao L
    Microbiol Spectr; 2022 Jun; 10(3):e0058622. PubMed ID: 35446152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary metabolomic analysis to identify potential markers for the diagnosis of tuberculosis and latent tuberculosis.
    Deng J; Liu L; Yang Q; Wei C; Zhang H; Xin H; Pan S; Liu Z; Wang D; Liu B; Gao L; Liu R; Pang Y; Chen X; Zheng J; Jin Q
    Arch Biochem Biophys; 2021 Jun; 704():108876. PubMed ID: 33864753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum metabolomics in latent pneumoconiosis tuberculosis patients based on ultra performance liquid chromatography tandem quadrupole time of flight mass spectrometry].
    Peng FD; Wang YJ; Zhang B; Gao HL; Tang AH; Qian QJ; Ding CG
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2020 Apr; 38(4):246-250. PubMed ID: 32447884
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of Mycobacterium tuberculosis Peptides in Serum Extracellular Vesicles from Persons with Latent Tuberculosis Infection.
    Mehaffy C; Kruh-Garcia NA; Graham B; Jarlsberg LG; Willyerd CE; Borisov A; Sterling TR; Nahid P; Dobos KM
    J Clin Microbiol; 2020 May; 58(6):. PubMed ID: 32245831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of serum biomarkers for active pulmonary tuberculosis using a targeted metabolomics approach.
    Cho Y; Park Y; Sim B; Kim J; Lee H; Cho SN; Kang YA; Lee SG
    Sci Rep; 2020 Mar; 10(1):3825. PubMed ID: 32123207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic analysis of infected primary human leucocytes revealed PSTK as potential treatment-monitoring marker for active and latent tuberculosis.
    Kaewseekhao B; Roytrakul S; Yingchutrakul Y; Salao K; Reechaipichitkul W; Faksri K
    PLoS One; 2020; 15(4):e0231834. PubMed ID: 32298370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined analysis of whole blood interferon gamma release assay and complete blood count analysis for rapid discrimination of active tuberculosis and latent tuberculosis infection.
    Kang YJ; Park H; Park SB; Kim J; Lee J; Kim J; Park S; Lee YS; Kim S
    J Clin Tuberc Other Mycobact Dis; 2021 Aug; 24():100253. PubMed ID: 34278005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reprogramming of Small Noncoding RNA Populations in Peripheral Blood Reveals Host Biomarkers for Latent and Active Mycobacterium tuberculosis Infection.
    de Araujo LS; Ribeiro-Alves M; Leal-Calvo T; Leung J; Durán V; Samir M; Talbot S; Tallam A; Mello FCQ; Geffers R; Saad MHF; Pessler F
    mBio; 2019 Dec; 10(6):. PubMed ID: 31796535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of Response to HBHA in HIV-Infected Patients with Latent Tuberculosis Infection.
    Delogu G; Vanini V; Cuzzi G; Chiacchio T; De Maio F; Battah B; Pinnetti C; Sampaolesi A; Antinori A; Goletti D
    Scand J Immunol; 2016 Dec; 84(6):344-352. PubMed ID: 27636597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomics Strategy Assisted by Transcriptomics Analysis to Identify Potential Biomarkers Associated with Tuberculosis.
    Jiang J; Li Z; Chen C; Jiang W; Xu B; Zhao Q
    Infect Drug Resist; 2021; 14():4795-4807. PubMed ID: 34815677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advancing new diagnostic tests for latent tuberculosis infection due to multidrug-resistant strains of Mycobacterium tuberculosis - End of the road?
    Mwaba P; Chakaya JM; Petersen E; Wejse C; Zumla A; Kapata N
    Int J Infect Dis; 2020 Mar; 92S():S69-S71. PubMed ID: 32119979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement Component C1q as Serum Biomarker to Detect Active Tuberculosis.
    Lubbers R; Sutherland JS; Goletti D; de Paus RA; van Moorsel CHM; Veltkamp M; Vestjens SMT; Bos WJW; Petrone L; Del Nonno F; Bajema IM; Dijkman K; Verreck FAW; Walzl G; Gelderman KA; Groeneveld GH; Geluk A; Ottenhoff THM; Joosten SA; Trouw LA
    Front Immunol; 2018; 9():2427. PubMed ID: 30405622
    [No Abstract]   [Full Text] [Related]  

  • 20. Biomarker discovery for tuberculosis using metabolomics.
    Yu Y; Jiang XX; Li JC
    Front Mol Biosci; 2023; 10():1099654. PubMed ID: 36891238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.